GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 25.20
-0.45 (-1.75%)
At close: Jul 9, 2026
GlycoNex Incorporation Market Cap
GlycoNex Incorporation has a market cap or net worth of 2.84 billion as of July 9, 2026. Its market cap has increased by 1.37% in one year.
Market Cap
2.84B
Enterprise Value
2.70B
Revenue
36.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.20
Market Cap Chart
Since December 16, 2011, GlycoNex Incorporation's market cap has increased from 1.51B to 2.84B, an increase of 88.09%. That is a compound annual growth rate of 4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.84B | 1.76% |
| Dec 31, 2025 | 2.79B | 2.79% |
| Dec 31, 2024 | 2.71B | -16.13% |
| Dec 29, 2023 | 3.23B | -0.89% |
| Dec 30, 2022 | 3.26B | 13.02% |
| Dec 30, 2021 | 2.89B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagittarius Life Science | 3.54B |
| SYN-TECH Chem. & Pharm. | 3.33B |
| Energenesis Biomedical CO.,LTD. | 3.29B |
| BioGend Therapeutics | 3.27B |
| Shine-On BioMedical | 3.18B |
| Chunghwa Chemical Synthesis & Biotech | 3.04B |
| Apex Biotechnology | 2.99B |
| BRIM Biotechnology | 2.92B |